During the past decade, Shanghai Tongji Hospital, Tongji University School of Medicine conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanghai Tongji Hospital, Tongji University School of Medicine" #1 sponsor was "Shanghai East Hospital" with 5 trials, followed by "Shanghai Tongji Hospital, Tongji University School of Medicine" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Shanghai 10th People's Hospital" with 3 trials sponsored and "Bayer" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shanghai Tongji Hospital, Tongji University School of Medicine" #1 collaborator was "Shanghai Tongji Hospital, Tongji University School of Medicine" with 7 trials as a collaborator, "Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University" with 3 trials as a collaborator, "Shanghai Zhongshan Hospital" with 3 trials as a collaborator, "Changhai Hospital" with 2 trials as a collaborator and "Eisai Inc." with 2 trials as a collaborator. Other collaborators include 49 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Shanghai Tongji Hospital, Tongji University School of Medicine" are "Prostate Cancer" (5 trials), "Portal Hypertension" (3 trials), "Cirrhosis, Liver" (2 trials), "Head and Neck Squamous Cell Carcinoma" (2 trials) and "Abiraterone Acetate" (1 trials). Many other conditions were trialed in "Shanghai Tongji Hospital, Tongji University School of Medicine" in a lesser frequency.

Most popular intervention types in "Shanghai Tongji Hospital, Tongji University School of Medicine" are "Drug" (11 trials), "Procedure" (6 trials), "Diagnostic Test" (5 trials), "Biological" (4 trials) and "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Lenvatinib" (2 trials), "Pembrolizumab" (2 trials), "3D-vHPS" (1 trials) and "48-hour blood pressure ambulatory monitoring" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanghai Tongji Hospital, Tongji University School of Medicine" are 24 trials for "All" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Shanghai Tongji Hospital, Tongji University School of Medicine". 5 are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Shanghai Tongji Hospital, Tongji University School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Shanghai Tongji Hospital, Tongji University School of Medicine, 4 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".